Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain

Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain

Abstract Aims The objective of this study was to investigate the prognostic value of urinary N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) compared with plasma NT‐proBNP in patients presenting with acute chest pain in the emergency department. Methods and results We measured simultaneously pl...

Full description

Bibliographic Details
Main Authors:	Stefanie Reynen, Michael Schlossbauer, Ute Hubauer, Julian Hupf, Arno Mohr, Evelyn Orso, Markus Zimmermann, Andreas Luchner, Lars S. Maier, Stefan Wallner, Carsten G. Jungbauer
Format:	Article
Language:	English
Published:	Wiley 2021-06-01
Series:	ESC Heart Failure
Subjects:	Urinary NT‐proBNP Acute chest pain Cardiac markers Natriuretic peptides
Online Access:	https://doi.org/10.1002/ehf2.13332

Similar Items

N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity
by: F. Fernandes, et al.
Published: (2007-02-01)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
by: Brian Kerr, et al.
Published: (2022-12-01)

Natriuretic peptides: Diagnostic and therapeutic use
by: Kaushik Pandit, et al.
Published: (2011-01-01)

Influence of preoperative serum N-terminal pro-brain type natriuretic peptide on the postoperative outcome and survival rates of coronary artery bypass patients
by: Thomas Schachner, et al.
Published: (2010-01-01)

Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis
by: Demóstenes G.L. Ribeiro, et al.
Published: (2014-06-01)

Correlation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) with radiographic features of congestion in chest CT scan of patients with COVID-19
by: Naghmeh Ziaie, et al.
Published: (2023-07-01)

Using N-terminal pro-B-type natriuretic peptide to diagnose cardiac abnormalities in children with dyspneaen with dyspnea
by: Zakaria Mukalla, et al.
Published: (2017-06-01)

Investigating the Role of Brain Natriuretic Peptide (BNP) and N-Terminal-proBNP in Thrombosis and Acute Ischemic Stroke Etiology
by: Rosanna Rossi, et al.
Published: (2024-03-01)

N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial
by: Gottsauner-Wolf Michael, et al.
Published: (2011-04-01)

Effect of feline characteristics on plasma N‐terminal‐prohormone B‐type natriuretic peptide concentration and comparison of a point‐of‐care test and an ELISA test
by: Sofia Hanås, et al.
Published: (2020-05-01)

The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
by: Zhu Q, et al.
Published: (2016-02-01)

Kadar N-Terminal Pro-Brain Natriuretic Peptide sebagai Prediktor Luaran Klinis Sindrom Koroner Akut
by: Florencia Idajanti Tandhana, et al.
Published: (2012-06-01)

N‐terminal pro brain natriuretic peptide reference values in community‐dwelling older adults
by: Ulrike Braisch, et al.
Published: (2022-06-01)

Prognostic association of plasma NT-proBNP levels in patients with microvascular angina -A report from the international cohort study by COVADIS-
by: Akira Suda, et al.
Published: (2022-12-01)

The Indian Consensus Document on cardiac biomarker
by: I. Satyamurthy, et al.
Published: (2014-01-01)

Sex and N-terminal pro B-type natriuretic peptide: The potential mediating role of iron biomarkers
by: Farnaz Khatami, et al.
Published: (2022-11-01)

N-TerminalPro-B-TypeNatriuretic Peptide For Detecting Early Cardiac Dysfunction in Patients with Thyroid Dysfunction
by: Makbule Ulusoy, et al.
Published: (2013-09-01)

N-terminal proBrain Natriuretic Peptide as Indicator of Left Ventricle Hypertrophy In Hypertensive Patients Compared with Left Ventricle Mass Index in Echocardiography
by: Mohammad Ariful Munir, et al.
Published: (2013-06-01)

Diagnostic value of NT–PRO BNP in cardiogenic and non cardiogenic pleural effusions
by: Mohamed E. Abdalla, et al.
Published: (2012-07-01)

Relationship between renalase and N-terminal pro-B-type Natriuretic Peptide (NT pro-BNP) in haemodialysis patients
by: Marcin Dziedzic, et al.
Published: (2014-03-01)

Highest Obesity Category Associated With Largest Decrease in N‐Terminal Pro‐B‐Type Natriuretic Peptide in Patients Hospitalized With Heart Failure With Preserved Ejection Fraction
by: Joban Vaishnav, et al.
Published: (2020-08-01)

ANALYSIS OF CHANGE IN NT-proBNP AFTER ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY IN PATIENT WITH HEART FAILURE
by: Intan Kusuma Dewi, et al.
Published: (2017-08-01)

Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective
by: Nagib Dahdah, et al.
Published: (2013-01-01)

Value of circulating N-terminal pro-brain natriuretic peptide for prognosis of cardiovascular events in patients with non-Hodgkin lymphoma in remission
by: B. B. Samura
Published: (2015-12-01)

RETRACTED: N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-proBNP) IN STAGE 1 AND STAGE 2 HYPERTENSION PATIENTS
by: Supriati Wila Djami
Published: (2019-10-01)

N-Terminal Pro B-Type Natriuretic Peptide's Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors
by: Elena Palà, et al.
Published: (2019-11-01)

The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure
by: Fu S, et al.
Published: (2015-01-01)

Predictive value of circulating N-terminal pro-brain natriuretic peptide in patients after treatment of Hodgkin lymphoma (a 3-year prospective study)
by: B. B. Samura
Published: (2017-12-01)

N-Terminal Prohormone of Brain Natriuretic Peptide but not C-Terminal Pre-Pro Vasopressin (Copeptin) Level is Associated with the Response to Antihypertensive Therapy in Haemodialysis Patients
by: Katarzyna Wyskida, et al.
Published: (2017-11-01)

N‐Terminal pro‐B‐type natriuretic peptide and stroke risk across a spectrum of cerebrovascular disease: The REasons for Geographic and Racial Differences in Stroke cohort
by: Kara K. Landry, et al.
Published: (2020-07-01)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)

A Differential Profile of Biomarkers between Patients with Atrial Fibrillation and Healthy Controls
by: Ana Merino-Merino, et al.
Published: (2022-08-01)

NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
by: Stefano Ciardullo, et al.
Published: (2022-11-01)

Longitudinal association between N-terminal B-type natriuretic peptide, anxiety and social support in patients with HFpEF: results from the multicentre randomized controlled Aldo-DHF trial
by: Marieke R. Wilke, et al.
Published: (2023-04-01)

Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR Registry
by: Lena Hinrichs, et al.
Published: (2020-05-01)

B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer?
by: Renato de Falco, et al.
Published: (2021-06-01)

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis
by: Stefanie Hendricks, et al.
Published: (2022-10-01)

Diagnosing heart failure in primary care: individual patient data meta‐analysis of two European prospective studies
by: Andrea K. Roalfe, et al.
Published: (2021-06-01)

A Clinical Study of the N-Terminal pro-Brain Natriuretic Peptide in Myocardial Injury after Neonatal Asphyxia
by: Rui Zhu, et al.
Published: (2016-04-01)

Evaluation of Serum Levels of N-terminal Pro Brain Natriuretic Peptide and Atrial Natriuretic Peptide in Neonates with Respiratory Distress
by: Noor Mohammad Noori, et al.
Published: (2016-06-01)